An immunodominant SSX-2–derived epitope recognized by CD4⁺ T cells in association with HLA-DR
J. Clin. Invest. Maha Ayyoub, et al. 113:1225 doi:10.1172/JCI20667 [Go to this article.]

Table 2
The ability of molecularly typed APCs to present peptide SSX-2_37–58 to specific, HLA-DR–restricted, CD4⁺ T cells was assessed by intracellular IFN-γ staining